IL2 and Hepatic fibrosis: Compared to the untreated liver fibrosis group, the expression of inflammatory factors including IL-1, IL-2, IL-6, IL-8, IL-10, and TNF-α were significantly decreased in the hBM-MSCs and hBM-MSCs-Ex treatment groups (Fig. 3g–l, p < 0.05).